Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 287640, 16 pages
http://dx.doi.org/10.1155/2015/287640
Review Article

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy

1Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al-’Abdiyah Campus, P. O. Box 7607, Makkah, Saudi Arabia
2Department of Pharmacology, Faculty of Medicine, Assiut University, Assiut 6515, Egypt
3Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia
4Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia

Received 10 January 2015; Revised 27 February 2015; Accepted 27 February 2015

Academic Editor: Limin Chen

Copyright © 2015 Bassem Refaat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, and Esam Azhar, “Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy,” Mediators of Inflammation, vol. 2015, Article ID 287640, 16 pages, 2015. doi:10.1155/2015/287640